CLASS I ONGOING Device recall · Reported 21 May 2025 · FDA Enforcement Report

MedicaLyte Liquid Bicarbonate Concentrate recalled

Nipro Renal Soultions USA is recalling MedicaLyte Liquid Bicarbonate Concentrate, distributed nationwide in the US. The recall was initiated on 11 Apr 2025 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesa. Model Number: BC+201 (45X). Case UDI-DI: 10817411022821, Bottle UDI-DI: 00817411022824. All lot numbers. b. Model Number: BC+100 36.83X. Case UDI-DI: 10817411022814, Bottle UDI-DI 00817411022817. Lot Numbers: N3C014, N3C018, N3F018, N4C010, N4C012, N4E004, N4L021, N4L022, N4L037, N5A044.
Quantity recalled816,840 units (BC+201), 39,228 units (BC+100)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1730-2025
FDA event ID
96646
Recalling firm
Nipro Renal Soultions USA, Lewisberry, PA
Classification
Class I
Status
Ongoing
Recall initiated
11 Apr 2025
FDA classified
14 May 2025
Reported
21 May 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

11 Apr 2025Recall initiated by company
14 May 2025Classified by FDA+33 days
21 May 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for the presence of visible foreign matter.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

MedicaLyte Liquid Bicarbonate Concentrate. Model Numbers: BC+201 (45X), BC+100 36.83X. Plastic bottle packaged in corrugated shipper cases (4 bottles per shipper case).

Where it was distributed

US Nationwide distribution in the states of AZ, CA, CO, DE, FL, GA, IL, KS, LA, MA, MI, MN, MO, NC, NJ, NV, NY, OH, OK, OR, PA, SC, TX, UT, VA, WA, PR. International distribution to Guatemala and Panama.

Nationwide ArizonaCaliforniaColoradoDelawareFloridaGeorgiaIllinoisKansasLouisianaMassachusettsMichiganMinnesotaMissouriNorth CarolinaNew JerseyNevadaNew YorkOhioOklahomaOregon

Questions about this recall

Why was it recalled?

Potential for the presence of visible foreign matter.

Which lots are affected?

a. Model Number: BC+201 (45X). Case UDI-DI: 10817411022821, Bottle UDI-DI: 00817411022824. All lot numbers. b. Model Number: BC+100 36.83X. Case UDI-DI: 10817411022814, Bottle UDI-DI 00817411022817. Lot Numbers: N3C014, N3C018, N3F018, N4C010, N4C012, N4E004, N4L021, N4L022, N4L037, N5A044.

Where was it sold?

US Nationwide distribution in the states of AZ, CA, CO, DE, FL, GA, IL, KS, LA, MA, MI, MN, MO, NC, NJ, NV, NY, OH, OK, OR, PA, SC, TX, UT, VA, WA, PR. International distribution to Guatemala and Panama.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Nipro Renal Soultions USA

All 6

Other Hip & Knee Implants recalls

All 3,097